Abstract
From its inception, multiphasic screening captured the imagination of the medical profession. Glowing articles depicted the vast amounts of unsuspected disease that could be diagnosed early, often in preclinical stages, with dramatic declines in the need for hospitalization and tremendous cost savings. Unfortunately, the early enthusiasm was clearly overstated. Multiphasic screening turned out to be a mixed blessing. Elsewhere in this issue, 1 Donald M. Berwick discusses screening in health fairs, a most appropriate topic at a time of focus on the burgeoning costs of medical care. Berwick states that in 1984, "health fairs across the nation performed 1.5 million measurements of height and weight, 300,000 tests for glaucoma, 200,000 hearing screens, and nearly 20 million blood chemistry tests." Health fairs thus have substantial potential to aid (or hurt) patients and to support (or diminish) physicians' efforts and thereby impact medical costs. In a large sample of participants in health
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
